SPG Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results Telomir Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss as Revenue Remains Absent Indian Equities Remain Under Foreign Selling Pressure Amid Outperformance of US Markets Lamar Advertising LAMR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response DIOD Q1 2026 Earnings Strong EPS Beat Masks Revenue Footprint Concerns Navigating the New Landscape Investing in an Era of Government Scarcity and SelfReliance CVV Q1 2026 Earnings Loss Per Share of 025 as Company Navigates Operational Headwinds